Food and Drug Administration

Endocrinologic & Metabolic Drugs Advisory Committee

January 15, 2003


Aldurazyme® (laronidase)


The statements contained in this document(s) are those of the product's sponsor, not FDA, and FDA does not necessarily agree with the sponsor's statements. FDA has not made a final determination about the safety or effectiveness of the product described in this document.

Aldurazyme® (laronidase), Introduction, BioMarin (HTM) (PPT)

Aldurazyme® Recombinant Human a-L-Iduronidase, BioMarin (HTM) (PPT)

Laronidase for the Treatment of Mucopolysaccharidosis I, BioMarin Corp. (HTM) (PPT)